Description Renew Spray (CJC-1295 No DAC Ipamorelin) contains 10 mg CJC-1295 No DAC and 10 mg Ipamorelin, totaling 200 mcg per spray and 20 mg in total. Ipamorelin CAS number 170851-70-4 Molar Mass 711.868 g·mol⁻¹ Chemical Formula C38H49N9O5 IUPAC Name (2S)-6-Amino-2-[[(2R)-2-[[(2R)-2-[[(2S)-2-[(2-amino-2-methylpropanoyl)amino]-3-(4H-imidazol-4-yl)propanoyl]amino]-3-naphthalen-2-ylpropanoyl]amino]-3-phenylpropanoyl]amino]hexanamide Mod GRF 1-29/CJC-1295 No Dac CAS Number 86168-78-7 Molar Mass 3357.93 g·mol⁻¹ Chemical Formula C149H246N44O42S IUPAC Name L-Tyrosyl-L-alanyl-L-α-aspartyl-L-alanyl-L-isoleucyl-L-phenylalanyl-L-threonyl-L-asparaginyl-L-seryl-L-tyrosyl-L-arginyl-L-lysyl-L-valyl-L-leucylglycyl-L-glutaminyl-L-leucyl-L-seryl-L-alanyl-L-arginyl-L-lysyl-L-leucyl-L-leucyl-L-glutaminyl-L-α-aspartyl-L-isoleucyl-L-methionyl-L-seryl-L-argininamide Introduction Renew Spray is a research peptide formulation, blending CJC-1295 No DAC and Ipamorelin. Designed exclusively for research purposes, this innovative combination provides researchers with a valuable tool to explore growth-related processes, potential synergies, and therapeutic applications related to growth hormone regulation. Key Characteristics CJC-1295 No DAC is recognized for its role in stimulating growth hormone release. It contributes to the blend’s focus on growth-related research. Ipamorelin is known for its growth hormone-stimulating properties. It complements CJC-1295 No DAC in this research formulation. Note: Researchers may also consider the Ipamorelin Nasal Spray as an alternative delivery format for preclinical investigations. The CJC-1295 no DAC / Ipamorelin Blend provides a combined peptide option often used in growth hormone research. For single-agent studies, the Ipamorelin Peptide is widely utilized in controlled laboratory settings. Research Applications Renew Spray is formulated for researchers investigating growth-related processes, exploring potential synergies between CJC-1295 No DAC and Ipamorelin, and studying therapeutic applications related to growth hormone regulation. Research Benefits Potential for Synergistic Benefit Researchers may explore the combined effects of CJC-1295 No DAC and Ipamorelin, assessing potential synergies in growth-related processes. Ipamorelin and Weight Gain Studies may delve into Ipamorelin’s impact on weight gain, providing insights into its metabolic effects. CJC 1295 No DAC and Treatment of Growth Hormone Deficiency Researchers are encouraged to investigate the potential therapeutic applications of CJC-1295 No DAC in the treatment of growth hormone deficiency. Summary Renew Spray (CJC-1295 No DAC Ipamorelin) is a research peptide formulation designed for scientific exploration into growth-related processes. With a focus on potential synergistic benefits, metabolic effects related to weight gain, and therapeutic applications, this blend provides researchers with a versatile tool for in-depth studies. Disclaimer This content is presented exclusively for educational purposes and should not be construed as medical advice. THE MATERIALS REFERENCED HEREIN ARE EXCLUSIVELY INTENDED FOR LABORATORY AND RESEARCH USE. Any clinical research initiatives must be conducted under the guidance of the relevant Institutional Review Board (IRB). Similarly, preclinical research involving animals must comply with the directives of the Institutional Animal Care and Use Committee (IACUC), adhering to the standards delineated by the Animal Welfare Act (AWA). Our informational content is meticulously designed for research-oriented insights and is not a substitute for individual analysis and verification from credible sources before any purchasing decisions are made. Upon finalizing your order and payment, you explicitly acknowledge and agree to adhere to our Terms and Conditions. Customer contentment stands as our paramount concern. If you are dissatisfied with the product received, kindly contact us at 419-707-5450 or email our support team at [email protected]. IMPORTANT NOTICE: All products showcased on our platform are EXCLUSIVELY INTENDED FOR LABORATORY AND RESEARCH APPLICATIONS. They are expressly not intended for veterinary or human utilization. References Khavinson VKh. Peptides and Ageing. Neuro Endocrinol Lett. 2002;23 Suppl 3:11-144. PMID: 12374906. [Read More]. Timms M, Ganio K, Forbes G, Bailey S, Steel R. An immuno polymerase chain reaction screen for the detection of CJC-1295 and other growth hormone-releasing hormone analogs in equine plasma. Drug Test Anal. 2019 Jun;11(6):804-812. doi: 10.1002/dta.2554. Epub 2018 Dec 25. PMID: 30489688. [Read More].